Introduction of new oral antiplatelet drugs in myocardial infarction hospital network: initial experience Tomasz RakowskiArtur DziewierzDariusz Dudek Letter to the Editor Open access 30 April 2013 Pages: 243 - 245
Lemierre’s syndrome: the forgotten disease Katrine JohannesenUffe BødtgerOle Heltberg Report 18 May 2013 Pages: 246 - 248
Modern antiplatelet management of coronary artery bypass patients: a role of platelet function testing in decision making Mate PetricevicBojan BiocinaDavor Milicic Letter to the Editor 31 May 2013 Pages: 249 - 250
A 1-year drug utilization evaluation of protamine in hospitalized patients to identify possible future roles of heparin and low molecular weight heparin reversal agents Charles E. Mahan OriginalPaper 08 May 2013 Pages: 271 - 278
Prednisone versus high-dose dexamethasone for untreated primary immune thrombocytopenia. A retrospective study of the Japan Hematology & Oncology Clinical Study Group Kana SakamotoHideki NakasoneYoshinobu Kanda OriginalPaper 18 May 2013 Pages: 279 - 286
Clinical features in patients with pulmonary embolism at a community hospital: analysis of 4 years of data Navin BajajAndrew L. BozarthJames A. Pippim OriginalPaper 17 May 2013 Pages: 287 - 292
Discrepant ratios of arterial versus venous thrombosis in hemophilia A as compared with hemophilia B Antonio GirolamiIrene BertozziLuisa Sambado OriginalPaper 17 May 2013 Pages: 293 - 297
Resident performed two-point compression ultrasound is inadequate for diagnosis of deep vein thrombosis in the critically III Jonathan CaroniaAdrian SarzynskiBushra Mina OriginalPaper 31 May 2013 Pages: 298 - 302
The ultrasound contrast imaging properties of lipid microbubbles loaded with urokinase in dog livers and their thrombolytic effects when combined with low-frequency ultrasound in vitro Shu-Ting RenXiao-Ning KangBing Wang OriginalPaper 14 August 2013 Pages: 303 - 309
Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trial Bram J. GellerJessica L. MegaChristian T. Ruff OriginalPaper 17 July 2013 Pages: 310 - 316
Association of circulating factor seven activating protease (FSAP) and of oral Omega-3 fatty acids supplements with clinical outcome in patients with atrial fibrillation: the OMEGA-AF study Mariana S. ParahulevaSandip KanseAli Erdogan OriginalPaper 11 April 2013 Pages: 317 - 325
Intravascular blood sampling using the Thrombuster II catheter does not cause artifactual platelet activation Gabrielle J. PenningsJustine SiegwaldHarry C. Lowe OriginalPaper 30 May 2013 Pages: 326 - 330
Warfarin use and long-term outcomes in patients with acute myocardial infarction and atrial fibrillation James A. NelsonJohn P. VavalleRenato D. Lopes OriginalPaper 04 June 2013 Pages: 331 - 337
Influence of VKORC1 gene polymorphisms on the effect of oral vitamin K supplementation in over-anticoagulated patients Priccila ZuchinaliGabriela C. SouzaLuis E. Rohde OriginalPaper 15 June 2013 Pages: 338 - 344
Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention Monica VerdoiaLucia BarbieriGiuseppe De Luca OriginalPaper 23 June 2013 Pages: 345 - 352
Giant right atrial thrombus in premature newborn Ali BaykanAbdullah OzyurtNazmi Narin Report 21 May 2013 Pages: 353 - 355
Use of ticagrelor in patients with ST-elevation myocardial infarction undergoing thrombolysis John GoudevenosIoannis NtalasDimitrios Alexopoulos Letter to the Editor 17 July 2013 Pages: 356 - 357
Erratum to: Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation Fabiana RolliniAntonio Tello-MontoliuDominick J. Angiolillo Erratum 08 October 2013 Pages: 358 - 358
Percutaneous closure of left atrial appendage: device-indicated antiplatelet therapy may also lead to fatal bleeding. A call for evidence-based antiplatelet regimen Juan Ruiz-GarcíaRaúl Moreno Report 01 September 2013 Pages: 359 - 361
Antiplatelet therapy in prevention of cardio- and venous thromboembolic events Steven R. SteinhublJohn W. EikelboomRichard C. Becker ReviewPaper 13 November 2013 Pages: 362 - 371
Transitioning to and from the novel oral anticoagulants: a management strategy for clinicians Elsayed Abo-SalemRichard Becker ReviewPaper 11 February 2014 Pages: 372 - 379
Novel oral anticoagulants: pharmacology, coagulation measures, and considerations for reversal Larry R. Jackson IIRichard C. Becker ReviewPaper 09 August 2013 Pages: 380 - 391